U.S. Food and Drug Administration: First FDA-approved vaccine for the prevention of dengue disease in endemic regions
“The U.S. Food and Drug Administration announced [Wednesday] the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas. Dengue is endemic in the U.S. territories of American Samoa, Guam, Puerto Rico, and the U.S. Virgin Islands…” (5/1).